These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

579 related items for PubMed ID: 17331848

  • 1. Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD.
    Sebelin-Wulf K, Nguyen TD, Oertel S, Papp-Vary M, Trappe RU, Schulzki A, Pezzutto A, Riess H, Subklewe M.
    Transpl Immunol; 2007 Apr; 17(3):203-10. PubMed ID: 17331848
    [Abstract] [Full Text] [Related]

  • 2. Long-term carriers generate Epstein-Barr virus (EBV)-specific CD4(+) and CD8(+) polyfunctional T-cell responses which show immunodominance hierarchies of EBV proteins.
    Ning RJ, Xu XQ, Chan KH, Chiang AK.
    Immunology; 2011 Oct; 134(2):161-71. PubMed ID: 21896011
    [Abstract] [Full Text] [Related]

  • 3. Epstein Barr viral load monitoring by quantitative PCR in renal transplant patients.
    Merlino C, Cavallo R, Bergallo M, Giacchino F, Bollero C, Negro Ponzi A, Cavallo G.
    New Microbiol; 2003 Apr; 26(2):141-9. PubMed ID: 12737195
    [Abstract] [Full Text] [Related]

  • 4. Variable EBV DNA load distributions and heterogeneous EBV mRNA expression patterns in the circulation of solid organ versus stem cell transplant recipients.
    Greijer AE, Stevens SJ, Verkuijlen SA, Juwana H, Fleig SC, Verschuuren EA, Hepkema BG, Cornelissen JJ, Brooimans RA, Verdonck LF, Middeldorp JM.
    Clin Dev Immunol; 2012 Apr; 2012():543085. PubMed ID: 23346186
    [Abstract] [Full Text] [Related]

  • 5. Expansion of EBNA1-specific effector T cells in posttransplantation lymphoproliferative disorders.
    Jones K, Nourse JP, Morrison L, Nguyen-Van D, Moss DJ, Burrows SR, Gandhi MK.
    Blood; 2010 Sep 30; 116(13):2245-52. PubMed ID: 20562330
    [Abstract] [Full Text] [Related]

  • 6. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
    Merlino C, Giacchino F, Bergallo M, Bonello F, Bollero C, Segoloni GP, Cavallo R.
    G Ital Nefrol; 2003 Sep 30; 20(2):170-5. PubMed ID: 12746803
    [Abstract] [Full Text] [Related]

  • 7. Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler.
    Leung E, Shenton BK, Green K, Jackson G, Gould FK, Yap C, Talbot D.
    Transpl Infect Dis; 2004 Dec 30; 6(4):156-64. PubMed ID: 15762933
    [Abstract] [Full Text] [Related]

  • 8. T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells.
    Nowakowska J, Stuehler C, Egli A, Battegay M, Rauser G, Bantug GR, Brander C, Hess C, Khanna N.
    Cytotherapy; 2015 Sep 30; 17(9):1280-91. PubMed ID: 26276009
    [Abstract] [Full Text] [Related]

  • 9. Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients.
    Colombini E, Guzzo I, Morolli F, Longo G, Russo C, Lombardi A, Merli P, Barzon L, Murer L, Piga S, Ciofi Degli Atti ML, Locatelli F, Dello Strologo L.
    Pediatr Nephrol; 2017 Aug 30; 32(8):1433-1442. PubMed ID: 28280938
    [Abstract] [Full Text] [Related]

  • 10. EBV-specific T-cell immunity in pediatric solid organ graft recipients with posttransplantation lymphoproliferative disease.
    Wilsdorf N, Eiz-Vesper B, Henke-Gendo C, Diestelhorst J, Oschlies I, Hussein K, Pape L, Baumann U, Tönshoff B, Pohl M, Höcker B, Wingen AM, Klapper W, Kreipe H, Schulz TF, Klein C, Maecker-Kolhoff B.
    Transplantation; 2013 Jan 15; 95(1):247-55. PubMed ID: 23222899
    [Abstract] [Full Text] [Related]

  • 11. Lymphocyte subset at time of Epstein-Barr viremia post-allogeneic hematopoietic stem cell transplantation in children may predict development of post-transplant lymphoproliferative disease: CD8:CD20 ratio as a sensitive predictor.
    Althubaiti S, Ali S, Renzi S, Krueger J, Chiang KY, Schechter T, Punnett A, Ali M.
    Pediatr Transplant; 2019 Dec 15; 23(8):e13574. PubMed ID: 31496046
    [Abstract] [Full Text] [Related]

  • 12. The Changing Epidemiology of Posttransplant Lymphoproliferative Disorder in Adult Solid Organ Transplant Recipients Over 30 Years: A Single-center Experience.
    Peters AC, Akinwumi MS, Cervera C, Mabilangan C, Ghosh S, Lai R, Iafolla M, Doucette K, Preiksaitis JK.
    Transplantation; 2018 Sep 15; 102(9):1553-1562. PubMed ID: 29485513
    [Abstract] [Full Text] [Related]

  • 13. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients.
    Riddler SA, Breinig MC, McKnight JL.
    Blood; 1994 Aug 01; 84(3):972-84. PubMed ID: 8043879
    [Abstract] [Full Text] [Related]

  • 14. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56dimNKG2A+KIR- NK Cells and Contributes to Suboptimal Control of EBV in Immunosuppressed Children With Post-transplant Lymphoproliferative Disorder.
    Lam JKP, Azzi T, Hui KF, Wong AMG, McHugh D, Caduff N, Chan KH, Münz C, Chiang AKS.
    Front Immunol; 2020 Aug 01; 11():1231. PubMed ID: 32625211
    [Abstract] [Full Text] [Related]

  • 15. Quantitative Epstein-Barr virus shedding and its correlation with the risk of post-transplant lymphoproliferative disorder.
    Holman CJ, Karger AB, Mullan BD, Brundage RC, Balfour HH.
    Clin Transplant; 2012 Aug 01; 26(5):741-7. PubMed ID: 22385033
    [Abstract] [Full Text] [Related]

  • 16. Early impairment of CD8+ T cells immune response against Epstein-Barr virus (EBV) antigens associated with high level of circulating mononuclear EBV DNA load in HIV infection.
    Legoff J, Amiel C, Calisonni O, Fromentin D, Rajoely B, Abuaf N, Tartour E, Rozenbaum W, Bélec L, Nicolas JC.
    J Clin Immunol; 2004 Mar 01; 24(2):125-34. PubMed ID: 15024179
    [Abstract] [Full Text] [Related]

  • 17. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients.
    Lee TC, Savoldo B, Barshes NR, Rooney CM, Heslop HE, Gee AP, Caldwell Y, Scott JD, Goss JA.
    Clin Transplant; 2006 Mar 01; 20(3):389-93. PubMed ID: 16824159
    [Abstract] [Full Text] [Related]

  • 18. Relationship between CD8+ T-cell phenotype and function, Epstein-Barr virus load, and clinical outcome in pediatric renal transplant recipients: a prospective study.
    Baudouin V, Dehée A, Pédron-Grossetete B, Ansart-Pirenne H, Haddad E, Maisin A, Loirat C, Sterkers G.
    Transplantation; 2004 Jun 15; 77(11):1706-13. PubMed ID: 15201670
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus load in transplant patients: Early detection of post-transplant lymphoproliferative disorders.
    Fellner MD, Durand KA, Solernou V, Bosaleh A, Balbarrey Z, García de Dávila MT, Rodríguez M, Irazu L, Alonio LV, Picconi MA.
    Rev Argent Microbiol; 2016 Jun 15; 48(2):110-8. PubMed ID: 27157146
    [Abstract] [Full Text] [Related]

  • 20. Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects.
    Piriou ER, van Dort K, Nanlohy NM, van Oers MH, Miedema F, van Baarle D.
    Eur J Immunol; 2005 Mar 15; 35(3):796-805. PubMed ID: 15724243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.